This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Understand how to set withdrawal rates for index funds during retirement, balancing income needs with long-term growth and safety.
20,901 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
A high-profile murder case can rewrite the map of your finances. This article uses the Alex Murdaugh case to show pra...
A cross-chain breach targeting the Verus-Ethereum bridge drained more than $11 million, triggering renewed focus on s...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
The Lego Foundation unveils a five-year, $97 million plan with the International Rescue Committee to bring play-based...
This article breaks down APi Group's Q1 2026 earnings call, translating the numbers into actionable takeaways for inv...
An 11% one-day slide in the SPDR S&P Semiconductor ETF underscores how equal-weight funds magnify single-name moves, ...
A niche corner of the tech market has seen attention turn toward optical component makers. This article explains why ...
Strategy has boosted its Bitcoin holdings again, financing the move by selling stock and growing its asset base. Crit...
As data needs soar, memory makers like Micron Technology face a pivotal five-year horizon. This guide breaks down the...
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
BitGo's latest move adds to the crypto job-cut trend as it slashes about 15% of its workforce to refocus on stablecoi...